Vasco D. B. Bonifácio
Just in time dendrimers (PTDC/CTM/099452/2008)
Dendrimer-based report-eradication antineoplasic machines (PTDC/MEC-ONC/29327/2017)
Urease next-generation inhibition therapy (PTDC/MED-QUI/3542/2020)
Tackling multiple myeloma by osteoblast cross-regulation (AMGEN funding)
Cystathionine-β-synthase inhibition as a therapeutic approach in colorectal and lung cancer (Merck KGaA Germany funding)
Restani, R.B., Morgado, P.I., Ribeiro, M.P., Correia, I.J., Aguiar-Ricardo, A., Bonifácio, V.D.B. (2012). Biocompatible polyurea dendrimers with pH-dependent fluorescence. Angew. Chem. Int. Ed., 51, 5162-5165. https://doi.org/10.1002/anie.201200362
Cruz, A., Mota, P., Ramos, C., Pires, R.F., Mendes, C., Pais, J., Nunes, S.C., Bonifácio, V.D.B., Serpa, J. (2020). Polyurea dendrimer folate-targeted nanodelivery of L-buthionine sulfoximine as a tool to tackle ovarian cancer chemoresistance. Antioxidants, 9, 133. https://doi.org/10.3390/antiox9020133
Pires, R.F., Conde, J., Bonifácio, V.D.B. (2021). Osteogenic differentiation of human mesenchymal stem cells by the single action of luminescent polyurea oxide biodendrimers. ACS Appl. Bio Mater., 3, 9101-9108. https://doi.org/10.1021/acsabm.0c01315
Pinto,S.N., Mil-Homens, D., Pires, R.F., Alves, M.M., Serafim, G., Martinho, N., Melo, M., Fialho, A.M., Bonifácio, V.D.B. (2022). Core-shell polycationic polyurea pharmadendrimers: New-generation of sustainable broad-spectrum antibiotics and antifungals. Biomat. Sci., 10, 5197-5207. https://doi.org/10.1039/D2BM00679K
Furtado, A., Viveiros, R., Bonifácio, V.D.B., Melo, A., Casimiro, T. (2023). Biomolecular Fishing: Design, green synthesis and performance of L-leucine-molecularly imprinted polymers. ACS Omega, 8(10), 9179–9186. https://doi.org/10.1021/acsomega.2c05714.